Francesca Conradie

5 ta ish

University of the Witwatersrand

1. Treatment of Highly Drug-Resistant Pulmonary Tuberculosis

   Francesca Conradie, Andreas H. Diacon, Nosipho Ngubane +15

   MaqolaOAOchiq kirish20207 iqtibos

   ABIABI:AkademIndex/2026.other.006850

2. Bedaquiline–Pretomanid–Linezolid Regimens for Drug-Resistant Tuberculosis

   Francesca Conradie, Tatevik R. Bagdasaryan, Borisov Se +25

   MaqolaOAOchiq kirish20227 iqtibos

   ABIABI:AkademIndex/2026.other.006859

3. A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis

   Andrew Nunn, Patrick Phillips, Sarah Meredith +16

   MaqolaOAOchiq kirish20196 iqtibos

   ABIABI:AkademIndex/2026.other.006848

4. Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis

   Alexander S. Pym, Andreas H. Diacon, Shenjie Tang +13

   MaqolaOAOchiq kirish20152 iqtibos

   ABIABI:AkademIndex/2026.other.034200

5. Standardised shorter regimens <i>versus</i> individualised longer regimens for rifampin- or multidrug-resistant tuberculosis

   S.K. Abidi, Jay Achar, M.M. Assao Neino +34

   MaqolaOAOchiq kirishTuberculosis Research and EpidemiologyEuropean Respiratory Journal20191 iqtibos

   ABIABI:AkademIndex/2019.article.000020